Jazz Pharmaceuticals
JAZZ
JAZZ
452 hedge funds and large institutions have $7.28B invested in Jazz Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 136 increasing their positions, 166 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $7.37B → $7.28B (-$92.5M)
18% less repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 166
59% less call options, than puts
Call options by funds: $34.2M | Put options by funds: $83.6M
Holders
452
Holding in Top 10
3
Calls
$34.2M
Puts
$83.6M
Top Buyers
| 1 | +$144M | |
| 2 | +$70.6M | |
| 3 | +$56.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$41.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$35.5M |
Top Sellers
| 1 | -$188M | |
| 2 | -$97.2M | |
| 3 | -$57.4M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$41.5M |
| 5 |
Renaissance Technologies
New York
|
-$38M |